Total planned funding: $115,013,232
Allocations
Countries/Regions
India | $115,013,232 |
Organizational Types
Unknown | $59,618,300 |
NGO | $21,702,610 |
Own Agency | $20,492,322 |
University | $3,450,000 |
Implementing Agency | $3,100,000 |
FBO | $2,200,000 |
Multi-lateral Agency | $2,200,000 |
Private Contractor | $1,650,000 |
Host Country Government Agency | $600,000 |
Program Areas
Governance and Systems | $44,988,700 |
Prevention | $29,775,263 |
Management and Operations | $15,306,190 |
Care | $13,122,067 |
Testing | $6,142,877 |
Treatment | $5,678,135 |
Budget Codes
OHSS: Health Systems Strengthening | $23,240,938 |
HVSI: Strategic Information | $15,875,833 |
HVMS: Management and Operations | $15,306,190 |
HVOP: Sexual Prevention: Other Sexual Prevention | $15,073,889 |
HBHC: Care: Adult Care and Support | $8,180,324 |
HVCT: Testing: HIV Testing and Counseling | $6,142,877 |
HLAB: Laboratory Infrastructure | $5,871,929 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $5,805,155 |
HTXS: Treatment: Adult Treatment | $5,071,734 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,423,004 |
HVTB: Care: TB/HIV | $2,711,305 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $2,603,379 |
HKID: Care: Orphans and Vulnerable Children | $2,027,709 |
HMBL: Biomedical Prevention: Blood Safety | $1,869,836 |
PDTX: Treatment: Pediatric Treatment | $582,924 |
PDCS: Care: Pediatric Care and Support | $202,729 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$59,618,300
Countries/Regions
USG Aggregated Agencies:
$15,376,285
Countries/Regions
FHI 360:
$13,737,357
Countries/Regions
University of Washington:
$3,450,000
Countries/Regions